期 |
栏目 |
标题 |
文件 |
卷 93, 编号 1 (2021) |
Reviews |
BCG, muramylpeptides, trained immunity (part II): a low molecular weight alternative to multicomponent bacterial immunostimulants for prevention of respiratory infections during a pandemic |
(Rus)
|
卷 94, 编号 7 (2022) |
Original articles |
New opportunities for preventive anti-inflammatory therapy in the management of patients with moderate and severe COVID-19 |
(Rus)
|
卷 95, 编号 10 (2023) |
Original articles |
Efficacy and safety of bacterial lysate OM-85 in the treatment of uncomplicated acute respiratory infections: a double-blind, placebo-controlled, multicenter, randomized trial |
(Rus)
|
卷 96, 编号 1 (2024) |
Consensuns |
Efficacy, safety and prospects of using a combination of native type II collagen, methylsulfonylmethane, boswellic acids, vitamin C and vitamin D3 in knee osteoarthritis: a resolution of the Expert panel |
(Rus)
|
卷 95, 编号 12 (2023) |
Original articles |
Application of HS221GI in treatment of influenza and ARVI in adults: a new approach – managing virus-induced inflammation. Results of a double-blind, randomized, placebo-controlled, multicenter clinical trial |
(Rus)
|